Mechanisms of Chemotherapeutic Drug Resistance in Cancer Therapy-A Quick Review

Taiwanese Journal of Obstetrics and Gynecology

Volumn 48, Issue 3, 2009, Pages 239-244

  Liu, Fu Shing ^a  

^a SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

antineoplastic drug resistance; cancer; membrane transporters; multidrug resistance; stem cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRCA1 PROTEIN; BREAST CANCER RESISTANCE PROTEIN; CARBOPLATIN; CISPLATIN; DACTINOMYCIN; DAUNORUBICIN; DISULFIDE; DOXORUBICIN; ETOPOSIDE; GEFITINIB; GLYCOPROTEIN P; IMATINIB; IRINOTECAN; METHOTREXATE; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; OXALIPLATIN; PACLITAXEL; TOPOTECAN; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

BREAST CANCER; CANCER RESISTANCE; CANCER STEM CELL; CANCER THERAPY; CELL SURFACE; DOWN REGULATION; DRUG MECHANISM; DRUG PROTEIN BINDING; GENE EXPRESSION; GENE INTERACTION; HUMAN; OVARY CANCER; REVIEW; DRUG EFFECT; DRUG RESISTANCE; MULTIDRUG RESISTANCE; NEOPLASM; STEM CELL;

ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASMS; STEM CELLS;

EID: 73449126570     PISSN: None     EISSN: 10284559     Source Type: Journal    
DOI: 10.1016/S1028-4559(09)60296-5     Document Type: Review

References (16)

1. Huang Y. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy. Cancer Metastasis Rev 26 (2007) 183-201
2. Stavrovskaya A.A., and Stromskaya T.P. Transport proteins of the ABC family and multidrug resistance of tumor cells. Biochemistry 73 (2008) 592-604
3. Sarkadi B., Homolya L., Szakacs G., and Varadi A. Human multidrug resistance ABCB and ABCG transporters: participation in chemoimmunity defense system. Physiol Rev 86 (2006) 1179-1236
4. Hrycyna C.A., Ramachandra M., Ambudkar S.V., Ko Y.H., Pedersen P.L., Pastan I., and Gottesman M.M. Mechanism of action of human P-glycoprotein ATPase activity: photochemical cleavage during a catalytic transition state using orthovanadate reveals cross-talk between the two ATP sites. J Biol Chem 273 (1998) 16631-16634
5. Ambudkar S.V., Kimchi-Sarfaty C., Sauna Z.E., and Gottesman M.M. P-glycoprotein: from genomics to mechanism. Oncogene 22 (2003) 7468-7485
6. Bourguignon L., Peyrollier K., Xia W., and Gilad E. Hyaluronan-CD44 interaction activates stem cell marker, Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem 283 (2008) 17635-17651
7. Chang X.B. A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1. Cancer Metastasis Rev 26 (2007) 15-37
8. Chen Y.N., Mickley L.A., Schwartz A.M., Acton E.M., Hwang J., and Fojo A.T. Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein. J Biol Chem 265 (1990) 10073-10080
9. Robey R.W., Polgar O., Deeken J., To K.W., and Bates S.E. ABCG2: determining its relevance in clinical drug resistance. Cancer Metastasis Rev 26 (2007) 39-57
10. Kuo M.T., Chen H.H.W., Song I.S., Savaraj N., and Ishikawa T. The roles of copper transporters in cisplatin resistance. Cancer Metastasis Rev 26 (2007) 71-83
11. Wang D., and Lippard S.J. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4 (2005) 307-320
12. Siddik Z.H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22 (2003) 7265-7279
13. Samimi G., Safaei R., Katano K., et al. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin Cancer Res 10 (2004) 4661-4669
14. Samimi G., Varki N.M., Wilczynski S., Safaei R., Alberts D.S., and Howell S.B. Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients. Clin Cancer Res 9 (2003) 5853-5859
15. Donnenberg V.S., and Donnenberg A.D. Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J Clin Pharmacol 45 (2005) 872-877
16. Lou H., and Dean M. Targeted therapy for cancer stem cells: the patched pathway and ABC transporters. Oncogene 26 (2007) 1357-1360